6533b862fe1ef96bd12c64ca

RESEARCH PRODUCT

Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry

Andrejs ErglisIveta MintaleGustavs LatkovskisInga BalodeSanda JegereIveta BajareAldis RozenbergsNicola GreenlawRoberto FerrariPhilippe StegFor The Clarify Registry Investigators

subject

MaleMedicine (General)medicine.medical_specialtyWaistmedicine.medical_treatmentDiastoleCoronary artery disease; Latvia; Prevention; Risk factors; Medicine (all)Coronary artery diseaseBody Mass IndexNOCoronary artery diseaseR5-920Percutaneous Coronary InterventionGeneral & Internal MedicineInternal medicineSecondary PreventionmedicineHumansProspective StudiesRegistriesCoronary artery disease; Latvia; Risk factors; PreventionProspective cohort studyAgedMedicine(all)AspirinAspirinbusiness.industryPreventionMedicine (all)CLARIFY registry investigatorsPercutaneous coronary interventionMiddle Agedmedicine.diseaseLatviaBlood pressureRisk factorsEvidence-Based PracticeAutomotive EngineeringCardiologyFemaleWaist CircumferencebusinessBody mass indexmedicine.drug

description

Background and objective: Management of outpatients with stable coronary artery disease (CAD) is important in secondary prevention. The objective was to describe differences in the characteristics of CAD patients in Latvia compared with other countries. Materials and methods: CLARIFY is an ongoing international, prospective, observational, longitudinal registry of outpatients with CAD. Data regarding treated outpatients with established CAD from the CLARIFY registry in Latvia (n = 120) were compared with those from the rest of Central-Eastern Europe (CEE) (n = 2888) and worldwide (n = 33,163). Results: Patients in Latvia had a larger waist circumference (101 [95–109] vs. 99 [91–106] in CEE, 96.5 [88–105] cm worldwide

yearjournalcountryeditionlanguage
2015-08-04Medicina
https://doi.org/10.1016/j.medici.2015.05.004